{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:48:08Z","timestamp":1792054088332,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":179,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101844","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:22:10Z","timestamp":1783120930000},"page":"101844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intervening in p53-Induced Death Domain Protein 1 to Decrease Regulatory T Cell Recruitment Boosts the Effectiveness of Radiofrequency Ablation Combined With Anti\u2013Programmed Cell Death Protein-1 Therapy in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Xu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqiu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqiu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101844_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jcmgh.2026.101844_bib2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(24)00799-2","article-title":"Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial","volume":"404","author":"Chen","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2026.101844_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2026.101844_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib5","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.3748\/wjg.v19.i42.7316","article-title":"Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update","volume":"19","author":"Vivarelli","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib8","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.cgh.2023.04.005","article-title":"Liver transplantation 2023: status report, current and future challenges","volume":"21","author":"Terrault","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/MS9.0000000000001746","article-title":"Surgical resection for hepatocellular carcinoma: a single-centre's one decade of experience","volume":"86","author":"Syaiful","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jcmgh.2026.101844_bib10","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3748\/wjg.v22.i10.2993","article-title":"Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment","volume":"22","author":"Yang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib11","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/hep.23181","article-title":"Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis","volume":"50","author":"N'Kontchou","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/hep.23965","article-title":"Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study","volume":"53","author":"Rossi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejrad.2010.02.010","article-title":"Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation","volume":"79","author":"Yang","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12072-007-9040-3","article-title":"Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma","volume":"2","author":"Obara","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jcmgh.2026.101844_bib16","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ymthe.2022.08.004","article-title":"Targeting N(7)-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation","volume":"31","author":"Zhu","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcmgh.2026.101844_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2021.06.001","article-title":"Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation","volume":"518","author":"Chen","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2026.101844_bib18","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41388-018-0169-4","article-title":"Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation","volume":"37","author":"Su","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2026.101844_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2019.05.041","article-title":"Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner","volume":"460","author":"Tan","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2026.101844_bib20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.32585","article-title":"Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.onc.1210635","article-title":"p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress","volume":"27","author":"Cuenin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2026.101844_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1095432","article-title":"The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress","volume":"304","author":"Tinel","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101844_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2005.09.036","article-title":"PIDD mediates NF-kappaB activation in response to DNA damage","volume":"123","author":"Janssens","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101844_bib24","doi-asserted-by":"crossref","first-page":"14314","DOI":"10.1073\/pnas.0506475102","article-title":"Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD","volume":"102","author":"Berube","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101844_bib25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/cncr.30531","article-title":"Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma","volume":"123","author":"Kutlu","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2026.101844_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.21037\/hbsn-22-469","article-title":"A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights","volume":"12","author":"Xie","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jcmgh.2026.101844_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.amjsurg.2009.11.009","article-title":"Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence","volume":"200","author":"Ayav","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/j.jcmgh.2026.101844_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jamcollsurg.2008.01.020","article-title":"Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma","volume":"207","author":"Lam","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jcmgh.2026.101844_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3748\/wjg.v8.i3.393","article-title":"Radiofrequence ablation of liver cancers","volume":"8","author":"Liu","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bjs.9960","article-title":"Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas","volume":"103","author":"Kim","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.jcmgh.2026.101844_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21037\/tgh.2019.10.17","article-title":"Ablative therapies for hepatic and biliary tumors: endohepatology coming of age","volume":"5","author":"Satiya","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib33","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.26630","article-title":"Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma","volume":"59","author":"Cheng","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/hepr.12705","article-title":"Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation","volume":"47","author":"Ikemoto","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jcmgh.2026.101844_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1479-5876-11-273","article-title":"Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways","volume":"11","author":"Dong","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcmgh.2026.101844_bib36","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fonc.2020.01308","article-title":"Palliative radiofrequency ablation accelerates the residual tumor progression through increasing tumor-infiltrating MDSCs and reducing T-cell-mediated anti-tumor immune responses in animal model","volume":"10","author":"Wu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib37","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1038\/s41467-019-13204-3","article-title":"Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy","volume":"10","author":"Shi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101844_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/79102","article-title":"Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis","volume":"26","author":"Lin","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2026.101844_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.289728.116","article-title":"The PIDDosome activates p53 in response to supernumerary centrosomes","volume":"31","author":"Fava","year":"2017","journal-title":"Genes Dev"},{"key":"10.1016\/j.jcmgh.2026.101844_bib40","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-020-0556-6","article-title":"Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation","volume":"27","author":"Sladky","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcmgh.2026.101844_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tcb.2009.12.006","article-title":"The unpredictable caspase-2: what can it do?","volume":"20","author":"Vakifahmetoglu-Norberg","year":"2010","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib42","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1038\/onc.2017.169","article-title":"Caspase-2: an orphan enzyme out of the shadows","volume":"36","author":"Forsberg","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2026.101844_bib43","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.cdd.4401492","article-title":"The biochemical mechanism of caspase-2 activation","volume":"11","author":"Baliga","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcmgh.2026.101844_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2011.06.012","article-title":"Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop","volume":"43","author":"Oliver","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.jcmgh.2026.101844_bib45","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1089\/ars.2010.3499","article-title":"Role of MnSOD and p66shc in mitochondrial response to p53","volume":"15","author":"Pani","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jcmgh.2026.101844_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","article-title":"Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis","volume":"122","author":"Giorgio","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101844_bib47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1667\/RR0695.1","article-title":"Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species","volume":"166","author":"Jobling","year":"2006","journal-title":"Radiat Res"},{"key":"10.1016\/j.jcmgh.2026.101844_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/654594","article-title":"Transforming growth factor-beta and oxidative stress interplay: implications in tumorigenesis and cancer progression","volume":"2015","author":"Krsti\u0107","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jcmgh.2026.101844_bib49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10875-008-9240-1","article-title":"Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function","volume":"28","author":"Shevach","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi4613","article-title":"Transforming growth factor-beta1 in regulatory T cell biology","volume":"7","author":"Moreau","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib51","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2016.05.032","article-title":"CXCL10\/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation","volume":"65","author":"Li","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib52","article-title":"Complex role of regulatory T cells (Tregs) in the tumor microenvironment: their molecular mechanisms and bidirectional effects on cancer progression","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101844_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004605","article-title":"Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells","volume":"10","author":"Noyes","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jcmgh.2026.101844_bib54","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/cei\/uxac123","article-title":"Treg specialization and functions beyond immune suppression","volume":"211","author":"Astarita","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcmgh.2026.101844_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101844_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110986","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells","volume":"39","author":"Gu","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2026.101844_bib58","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.32419","article-title":"Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC","volume":"76","author":"Suthen","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib59","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/hep.32023","article-title":"Immunomodulatory effects of lenvatinib plus anti-programmed cell death protein 1 in mice and rationale for patient enrichment in hepatocellular carcinoma","volume":"74","author":"Torrens","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101844_bib60","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101844_bib61","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-\u03b3 drives Treg fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101844_bib62","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1002\/cpz1.211","article-title":"The DEN and CCl4-induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma","volume":"1","author":"Uehara","year":"2021","journal-title":"Curr Protoc Pharmacol"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:19:59Z","timestamp":1792052399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26001220"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101844","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intervening in p53-Induced Death Domain Protein 1 to Decrease Regulatory T Cell Recruitment Boosts the Effectiveness of Radiofrequency Ablation Combined With Anti\u2013Programmed Cell Death Protein-1 Therapy in Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101844"}}